Eldehna WM - Search Results

1

The Potential Roles of Ficus carica Extract in the Management of COVID-19 Viral Infections: A Computer-Aided Drug Design Study.

Hamed M, Khalifa M, El Hassab MA, Abourehab MAS, Al Kamaly O, Alanazi AS, Eldehna WM, Mansour FR. Hamed M, et al. Among authors: eldehna wm. Curr Comput Aided Drug Des. 2023 Aug 18. doi: 10.2174/1573409920666230818092445. Online ahead of print. Curr Comput Aided Drug Des. 2023. PMID: 37594095

2

Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations.

El Hassab MA, Shoun AA, Al-Rashood ST, Al-Warhi T, Eldehna WM. El Hassab MA, et al. Among authors: eldehna wm. Front Chem. 2020 Oct 30;8:584894. doi: 10.3389/fchem.2020.584894. eCollection 2020. Front Chem. 2020. PMID: 33195080 Free PMC article.

3

Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria.

Elsayed ZM, Eldehna WM, Abdel-Aziz MM, El Hassab MA, Elkaeed EB, Al-Warhi T, Abdel-Aziz HA, Abou-Seri SM, Mohammed ER. Elsayed ZM, et al. Among authors: eldehna wm. J Enzyme Inhib Med Chem. 2021 Dec;36(1):384-393. doi: 10.1080/14756366.2020.1868450. J Enzyme Inhib Med Chem. 2021. PMID: 33406941 Free PMC article.

4

Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations.

Eldehna WM, El Hassab MA, Abo-Ashour MF, Al-Warhi T, Elaasser MM, Safwat NA, Suliman H, Ahmed MF, Al-Rashood ST, Abdel-Aziz HA, El-Haggar R. Eldehna WM, et al. Bioorg Chem. 2021 May;110:104748. doi: 10.1016/j.bioorg.2021.104748. Epub 2021 Feb 18. Bioorg Chem. 2021. PMID: 33684714

5

In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches.

El Hassab MA, Ibrahim TM, Al-Rashood ST, Alharbi A, Eskandrani RO, Eldehna WM. El Hassab MA, et al. Among authors: eldehna wm. J Enzyme Inhib Med Chem. 2021 Dec;36(1):727-736. doi: 10.1080/14756366.2021.1885396. J Enzyme Inhib Med Chem. 2021. PMID: 33685335 Free PMC article.

6

Computational Prediction of the Potential Target of SARS-CoV-2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM-PBSA Calculations.

El Hassab MA, Hemeda LR, Elsayed ZM, Al-Rashood ST, Abdel-Hamid Amin MK, Abdel-Aziz HA, Eldehna WM. El Hassab MA, et al. Among authors: eldehna wm. Chem Biodivers. 2022 Feb;19(2):e202100719. doi: 10.1002/cbdv.202100719. Epub 2022 Jan 4. Chem Biodivers. 2022. PMID: 34813168 Free PMC article.

7

Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis.

Eldehna WM, El Hassab MA, Abdelshafi NA, Al-Zahraa Sayed F, Fares M, Al-Rashood ST, Elsayed ZM, Abdel-Aziz MM, Elkaeed EB, Elsabahy M, Eissa NG. Eldehna WM, et al. Int J Pharm. 2022 Jan 25;612:121369. doi: 10.1016/j.ijpharm.2021.121369. Epub 2021 Dec 11. Int J Pharm. 2022. PMID: 34906651

8

Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors.

El Hassab MA, Eldehna WM, Al-Rashood ST, Alharbi A, Eskandrani RO, Alkahtani HM, Elkaeed EB, Abou-Seri SM. El Hassab MA, et al. Among authors: eldehna wm. J Enzyme Inhib Med Chem. 2022 Dec;37(1):563-572. doi: 10.1080/14756366.2021.2022659. J Enzyme Inhib Med Chem. 2022. PMID: 35012384 Free PMC article.

9

GC/MS Profiling, Anti-Collagenase, Anti-Elastase, Anti-Tyrosinase and Anti-Hyaluronidase Activities of a Stenocarpus sinuatus Leaves Extract.

Younis MM, Ayoub IM, Mostafa NM, El Hassab MA, Eldehna WM, Al-Rashood ST, Eldahshan OA. Younis MM, et al. Among authors: eldehna wm. Plants (Basel). 2022 Mar 29;11(7):918. doi: 10.3390/plants11070918. Plants (Basel). 2022. PMID: 35406898 Free PMC article.

10

Identification of 3-(piperazinylmethyl)benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insights.

Eldehna WM, Maklad RM, Almahli H, Al-Warhi T, Elkaeed EB, Abourehab MAS, Abdel-Aziz HA, El Kerdawy AM. Eldehna WM, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):1227-1240. doi: 10.1080/14756366.2022.2062337. J Enzyme Inhib Med Chem. 2022. PMID: 35470754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page